IBB ETF (iShares Biotechnology ETF) is managed by iShares by BlackRock (US) with $8.50B in net assets. IBB expense ratio is 0.44%, holding 266 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2001-02-05.

IBB performance shows a YTD return of 3.73%. The 1-year return is 28.28% and the 5-year return is 2.49%. IBB dividend yield stands at 0.22%, paid quarterly.

IBB top holdings include Nvaesrtex Pharmaceuticals Inc (8.6%), Gilead Sciences Inc (8.0%), Amgen Inc. (7.8%), Regeneron Pharmaceuticals, Inc. (6.9%), Alnylam Pharmace (4.6%). View all IBB holdings, sector breakdown, or dividend history.

IBB can be compared against other funds using the overlap calculator or side-by-side comparison tool. IBB alternatives are available via the screener, along with tax-loss harvesting opportunities.